Table 3 Hematologic data and genetic modifiers for the 4 TI patients with β0/β0 genotype
From: Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine
Patient # | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
Age / age at diagnosis | 17/6 | 16/5 | 29/3 | 39/1 |
Age at first transfusion, years | 6 | 5 | < 1 | 1 |
Hb, g/dL | 7.7 | 8.6 | 9.8 | 8.7 |
MCV, fL | 66.5 | 91.8 | 76.4 | 99.0 |
MCH, pg/cell | 23.1 | 26.1 | 26.2 | 28.6 |
HbF, % | 68.0 | 67.0 | 83.0 | 46.8 |
HbA2, % | 2.3 | 1.8 | 2.3 | 2.9 |
β-thalassemia genotype | IVS-II-1/ IVS-II-1 | IVS-II-1/ IVS-II-1 | IVS-II-1/ IVS-II-1 | IVS-I-1/ Cd37 |
XmnI SNP γG − 158 C > T | +/+ | +/+ | +/+ | −/− |
α- thalassemia genotype | αα/αα | αα/αα | αα/αα | αIVSI(−5nt)α/ αα |